152 related articles for article (PubMed ID: 26433443)
1. Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: A survey of U.S. transplantation centers.
Gin GE; Pereira JF; Weinberg AD; Mehrazin R; Lerner SM; Sfakianos JP; Phillips CK
Urol Oncol; 2016 Feb; 34(2):57.e9-13. PubMed ID: 26433443
[TBL] [Abstract][Full Text] [Related]
2. Urologists' personal feelings on PSA screening and prostate cancer treatment.
Wenzler DL; Rosenberg BH
J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer.
Aminsharifi A; Simon R; Polascik TJ; Robertson CN; Sudan DL; Collins BH; Moul JW
J Urol; 2019 Sep; 202(3):469-474. PubMed ID: 30835631
[TBL] [Abstract][Full Text] [Related]
4. What Have Patients Been Hearing From Providers Since the 2012 USPSTF Recommendation Against Routine Prostate Cancer Screening?
Haider MR; Qureshi ZP; Horner R; Friedman DB; Bennett C
Clin Genitourin Cancer; 2017 Dec; 15(6):e977-e985. PubMed ID: 28625690
[TBL] [Abstract][Full Text] [Related]
5. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen testing: men's responses to 2012 recommendation against screening.
Squiers LB; Bann CM; Dolina SE; Tzeng J; McCormack L; Kamerow D
Am J Prev Med; 2013 Aug; 45(2):182-9. PubMed ID: 23867025
[TBL] [Abstract][Full Text] [Related]
7. PSA screening: determinants of primary-care physician practice patterns.
Tasian GE; Cooperberg MR; Potter MB; Cowan JE; Greene KL; Carroll PR; Chan JM
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):189-94. PubMed ID: 22343837
[TBL] [Abstract][Full Text] [Related]
8. Utility of Prostate Cancer Screening in Kidney Transplant Candidates.
Vitiello GA; Sayed BA; Wardenburg M; Perez SD; Keith CG; Canter DJ; Ogan K; Pearson TC; Turgeon N
J Am Soc Nephrol; 2016 Jul; 27(7):2157-63. PubMed ID: 26701982
[TBL] [Abstract][Full Text] [Related]
9. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.
Cohn JA; Wang CE; Lakeman JC; Silverstein JC; Brendler CB; Novakovic KR; McGuire MS; Helfand BT
Urol Oncol; 2014 Jan; 32(1):41.e23-30. PubMed ID: 23911680
[TBL] [Abstract][Full Text] [Related]
10. Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record.
Aminsharifi A; Schulman A; Anderson J; Fish L; Oeffinger K; Shah K; Sze C; Tay KJ; Tsivian E; Polascik TJ
Urol Oncol; 2018 Nov; 36(11):502.e1-502.e6. PubMed ID: 30170982
[TBL] [Abstract][Full Text] [Related]
11. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2012 Jul; 157(2):120-34. PubMed ID: 22801674
[TBL] [Abstract][Full Text] [Related]
12. Practice patterns in screening and management of prostate cancer in elderly men.
Konety BR; Sharp VJ; Verma M; Williams RD;
Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system.
Scosyrev E; Wu G; Golijanin D; Messing E
BJU Int; 2012 Nov; 110(10):1485-90. PubMed ID: 22448649
[TBL] [Abstract][Full Text] [Related]
14. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
Lim LS; Sherin K;
Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening practices and diagnoses in patients age 50 and older, Southeastern Michigan, pre/post 2012.
Rezaee ME; Ward CE; Odom BD; Pollock M
Prev Med; 2016 Jan; 82():73-6. PubMed ID: 26592690
[TBL] [Abstract][Full Text] [Related]
16. Follow-up Survey of Donor Candidates for Living Related Kidney Transplantation With Prostate Cancer.
Hata K; Iizuka J; Hashimoto Y; Takagi T; Kondo T; Omoto K; Shimizu T; Okumi M; Inui M; Ishida H; Tanabe K
Transplant Proc; 2018 Oct; 50(8):2338-2341. PubMed ID: 30316354
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer in renal transplant recipients.
Sherer BA; Warrior K; Godlewski K; Hertl M; Olaitan O; Nehra A; Deane LA
Int Braz J Urol; 2017; 43(6):1021-1032. PubMed ID: 28338305
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey.
Ross LE; Coates RJ; Breen N; Uhler RJ; Potosky AL; Blackman D
Prev Med; 2004 Jun; 38(6):732-44. PubMed ID: 15193893
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of prostate cancers in renal-transplant recipients.
Cormier L; Lechevallier E; Barrou B; Benoit G; Bensadoun H; Boudjema K; Descottes JL; Doré B; Guy L; Malavaud B; Martin X; Patard JJ; Petit J; Salomon L
Transplantation; 2003 Jan; 75(2):237-9. PubMed ID: 12548131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
